| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Norverapamil | LP17240-0 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Norverapamil | Serum or Plasma | Drug toxicology | LP389301-5 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ug/L | |
| EXAMPLE_UCUM_UNITS | ug/L | |
| UNITSREQUIRED | Y |
| LONG_COMMON_NAME | en-US | Norverapamil [Mass/volume] in Serum or Plasma |
| LONG_COMMON_NAME | en-US | Norverapamil [Mass/volume] in Serum or Plasma |
| SHORTNAME | en-US | Norverapamil SerPl-mCnc |
| ConsumerName | en-US | Norverapamil, Blood |
| SHORTNAME | es-AR | norverapamilo:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo: |
| SHORTNAME | pt-BR | Norverapamil SerPl-mCnc |
| LONG_COMMON_NAME | fr-FR | Norvérapamil [Masse/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Norverapamil [massa/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | Norverapamilo: Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77
FHIR